Fate Therapeutics Stock Target Price and Analyst Consensus
| FATE Stock | USD 1.37 0.06 4.58% |
The current analyst and expert consensus on Fate Therapeutics is Buy with 12 hold recommendations. The current projected Fate Therapeutics target price consensus is 6.31 with 18 analyst opinions. One of the most common ways Fate Therapeutics analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Fate Therapeutics vendors, executives, and/or customers. Fate Therapeutics recommendation module provides expert sentiment on the projected Fate Therapeutics target price to derive its highest and lowest estimates based on target price standard deviation of 6.8237.
Lowest Forecast 5.74 | Highest Forecast 7 | Target Price 6.31 |
Fate |
It's important to approach Fate Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Fate Therapeutics price targets
Fate Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Fate Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Fate Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Fate Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Fate Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Fate Therapeutics is a key component of Fate Therapeutics valuation and have some predictive power on the future returns of a Fate Therapeutics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Fate Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Investor Favorites Invested over 300 shares | |
 | Automobiles and Trucks Invested over 50 shares | |
 | Impulse Invested over 100 shares | |
 | Cash Cows Invested few shares | |
 | Banking Invested over 30 shares | |
 | FinTech Invested over 60 shares | |
 | Macroaxis Index Invested few shares | |
 | Momentum Invested over 300 shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Baby Boomer Prospects Invested over 60 shares | |
 | Driverless Cars Invested over 300 shares | |
 | Manufacturing Invested over 30 shares | |
 | ESG Investing Invested few shares |
Check out Macroaxis Advice on Fate Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Fate Stock refer to our How to Trade Fate Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Please note, the presentation of Fate Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Fate Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Fate Therapeutics' management manipulating its earnings.